343 related articles for article (PubMed ID: 15858285)
21. Variable capacity of 13 hepatitis B virus surface antigen assays for the detection of HBsAg mutants in blood samples.
Servant-Delmas A; Mercier-Darty M; Ly TD; Wind F; Alloui C; Sureau C; Laperche S
J Clin Virol; 2012 Apr; 53(4):338-45. PubMed ID: 22296790
[TBL] [Abstract][Full Text] [Related]
22. Naturally occurring MHR variants in Turkish patients infected with hepatitis B virus.
Sayiner AA; Ozcan A; Sengonul A
J Med Virol; 2008 Mar; 80(3):405-10. PubMed ID: 18205223
[TBL] [Abstract][Full Text] [Related]
23. [Requirement of standardizing anti-HBs assay methods in Japan for HBV infection-preventing strategy--discrepancy of anti-HBs measurements among three different kits widely used in Japan].
Ogata N
Rinsho Byori; 2006 Sep; 54(9):960-5. PubMed ID: 17063878
[TBL] [Abstract][Full Text] [Related]
24. [Sensitivity and specificity of 4 domestic ELISA kits for detection of hepatitis B virus markers].
Wu X; Zhou C; Huang WJ; Qi ZB; Liang ZL; Li HM; Zhuang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Sep; 29(9):915-8. PubMed ID: 19173858
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B virus genetic diversity.
Echevarría JM; Avellón A
J Med Virol; 2006; 78 Suppl 1():S36-42. PubMed ID: 16622876
[TBL] [Abstract][Full Text] [Related]
26. Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes.
Scheiblauer H; El-Nageh M; Diaz S; Nick S; Zeichhardt H; Grunert HP; Prince A
Vox Sang; 2010 Apr; 98(3 Pt 2):403-14. PubMed ID: 20412171
[TBL] [Abstract][Full Text] [Related]
27. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
[TBL] [Abstract][Full Text] [Related]
28. HBsAg diagnostic kits in the detection of hepatitis B virus mutation within "a" determinant.
Louisirirotchanakul S; Kanoksinsombat C; O'Charoen R; Fongsatikul L; Puapairoj C; Lulitanond V; Appassakij H; Promwong C; Wasi C
Viral Immunol; 2006; 19(1):108-14. PubMed ID: 16553556
[TBL] [Abstract][Full Text] [Related]
29. Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance.
Hsu CW; Yeh CT; Chang ML; Liaw YF
Gastroenterology; 2007 Feb; 132(2):543-50. PubMed ID: 17258721
[TBL] [Abstract][Full Text] [Related]
30. Detection of HBsAg mutants in a population with a low prevalence of hepatitis B virus infection.
Gibb R; Nimmo GR; O'Loughlin P; Lowe P; Drummond D
J Med Virol; 2007 Apr; 79(4):351-5. PubMed ID: 17311336
[TBL] [Abstract][Full Text] [Related]
31. Surveillance for hepatitis B surface antigen mutants.
Coleman PF
J Med Virol; 2006; 78 Suppl 1():S56-8. PubMed ID: 16622879
[TBL] [Abstract][Full Text] [Related]
32. Performance of hepatitis B surface antigen tests with the first WHO international hepatitis B virus genotype reference panel.
Chudy M; Scheiblauer H; Hanschmann KM; Kress J; Nick S; Wend U; Schüttler C; Nübling CM; Gerlich WH
J Clin Virol; 2013 Sep; 58(1):47-53. PubMed ID: 23829967
[TBL] [Abstract][Full Text] [Related]
33. Detection of HBsAg mutants.
Osiowy C
J Med Virol; 2006; 78 Suppl 1():S48-51. PubMed ID: 16622877
[TBL] [Abstract][Full Text] [Related]
34. Measurements in international units of antibody to hepatitis B surface antigen(anti-HBs) after immunization with a yeast-derived, subtype adr hepatitis B vaccine are considerably different between chemiluminescent immunoassay (CLIA) and chemiluminescent enzyme immunoassay (CLEIA).
Ogata N
Rinsho Byori; 2006 Apr; 54(4):340-3. PubMed ID: 16722452
[TBL] [Abstract][Full Text] [Related]
35. HBV genotype characterization and distribution in patients with HBV-related liver diseases in Zhejiang Province, P.R. China: possible association of co-infection with disease prevalence and severity.
Zumbika E; Ruan B; Xu CH; Ni Q; Hou W; Chen Z; Liu KZ
Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):535-43. PubMed ID: 16286258
[TBL] [Abstract][Full Text] [Related]
36. [Genetic variability of hepatitis B virus isolates among population of Shuryskarsky area of Yamal-Nenets autonomous region].
Manuĭlov VA; Netesova IG; Osipova LP; Shustov AV; Baiandin RB; Kochneva GV; Netesov SV
Mol Gen Mikrobiol Virusol; 2005; (4):30-4. PubMed ID: 16334223
[TBL] [Abstract][Full Text] [Related]
37. Multi-center evaluation of the hepatitis B surface antigen (HBsAg) assay and HbsAg confirmatory assay for the family of Access immunoassay systems.
Lunel-Fabiani F; Duburcq X; Levayer T; Descamps F; Maniez-Montreuil M; Pivert A; Ducancelle A; Pouzet A; Marant L; Clèment A; Duhamel D; Leirens Y; Margotteau F; Falcou-Briatte R; Heinen C; Bouniort F; Taskar S; Artus A; Woodrum D; Flecheux O
Clin Lab; 2010; 56(7-8):281-90. PubMed ID: 20857892
[TBL] [Abstract][Full Text] [Related]
38. Do we need an 'in-house' neutralization assay for confirmation of hepatitis B surface antigen? Answers from a tertiary care hospital in India.
Fletcher GJ; Gnanamony M; David J; Ismail AM; Subramani T; Abraham P
J Gastroenterol Hepatol; 2010 May; 25(5):942-5. PubMed ID: 19929924
[TBL] [Abstract][Full Text] [Related]
39. What can be revealed by extending the sensitivity of HBsAg detection to below the present limit?
Togashi H; Hashimoto C; Yokozawa J; Suzuki A; Sugahara K; Saito T; Yamaguchi I; Badawi H; Kainuma N; Aoyama M; Ohya H; Akatsuka T; Tanaka Y; Mizokami M; Kawata S
J Hepatol; 2008 Jul; 49(1):17-24. PubMed ID: 18479773
[TBL] [Abstract][Full Text] [Related]
40. Age- and gender-specific distributions of hepatitis B virus (HBV) genotypes in Japanese HBV-positive blood donors.
Yoshikawa A; Gotanda Y; Suzuki Y; Tanaka M; Matsukura H; Shiraishi T; Matsubayashi K; Kon E; Suzuki K; Yugi H;
Transfusion; 2009 Jul; 49(7):1314-20. PubMed ID: 19389027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
